Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed No phase listed Observational

Immunophenotyping Assessment in a COVID-19 Cohort

ClinicalTrials.gov ID: NCT04378777

Public ClinicalTrials.gov record NCT04378777. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 21, 2026, 8:29 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Prospective Cohort Study to Assess Longitudinal Immune Responses in Hospitalized Patients With COVID-19 (DAIT-COVID-19-002)

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

This surveillance study will collect detailed clinical, laboratory, and radiographic data in coordination with biologic sampling of blood and respiratory secretions and viral shedding in nasal secretions in order to identify immunophenotypic and genomic features of COVID-19 -related susceptibility and/or progression. The aim: for the results obtained from this study to assist in generating hypotheses for effective host-directed therapeutic interventions, to help to prioritize proposals for such interventions, and/or optimize timing for administration of host-response directed therapeutics.

Study identification

NCT ID
NCT04378777
Recruitment status
Completed
Study type
Observational
Phase
Not listed
Enrollment
1,227 participants

Conditions and interventions

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
May 1, 2020 (Actual)
Primary completion
Mar 19, 2021 (Actual)
Completion
Apr 21, 2022 (Actual)
Last update posted
May 19, 2022

2020 – 2022

United States locations

U.S. sites
17
U.S. states
12
U.S. cities
17
Facility City State ZIP Site status
University of Arizona (UA) College of Medicine - Tucson: UA Health Sciences Asthma and Airway Disease Research Center Tucson Arizona 85724 —
University of California, Los Angeles: Department of Medicine Los Angeles California 90024 —
University of California San Francisco School of Medicine San Francisco California 94115 —
Stanford Medicine: Sean N. Parker Center for Allergy & Asthma Research Stanford California 94305 —
Yale School of Medicine New Haven Connecticut 06520 —
University of Florida Health Gainesville Gainesville Florida 32608 —
University of Florida Health Jacksonville Jacksonville Florida 32209 —
University of South Florida Health Tampa Tampa Florida 33606 —
Emory University School of Medicine Atlanta Georgia 30317 —
Brigham and Women's Hospital Boston Massachusetts 02115 —
Icahn School of Medicine at Mount Sinai New York New York 10029 —
University Hospitals Case Medical Center Cleveland Ohio 44106 —
University of Oklahoma ,Oklahoma Health Sciences Center: Pulmonary/Critical Care, Department of Medicine Oklahoma City Oklahoma 73126 —
Oregon Health & Science University Portland Oregon 97239 —
Drexel University College of Medicine Philadelphia Pennsylvania 19102 —
University of Texas at Austin: UT Health Austin Austin Texas 78712 —
Baylor College of Medicine: Department of Medicine Houston Texas 77030 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT04378777, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted May 19, 2022 · Synced Oct 21, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT04378777 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →